RecruitingNCT03731130

Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer

Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer


Sponsor

Ludwig-Maximilians - University of Munich

Enrollment

100 participants

Start Date

Oct 5, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional Outcome, oncological outcome and toxicity in patients treated with neoadjuvant short term radiation or long-term chemoradiation followed by surgery


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is observing how quality of life changes for people with rectal cancer who receive radiation or chemoradiation therapy before surgery, tracking how patients feel throughout their treatment journey. **You may be eligible if...** - You have been diagnosed with rectal cancer (confirmed by biopsy), without spread to other organs - Your medical team has recommended pre-surgery radiation or chemoradiation treatment - You are 18 years or older - You are willing to complete standardized questionnaires about your quality of life **You may NOT be eligible if...** - You are under 18 years of age - You have already received systemic therapy (chemotherapy) for your rectal cancer - Your cancer has spread to other organs (distant metastasis) - You have another active cancer at the same time Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREORTC QLQ C30

standardized questionaire

OTHEREORTC QLQ CR29

standardized questionaire


Locations(1)

Department of Radiation Oncology, University Hospital, LMU Munich

Munich, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03731130


Related Trials